HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barroso, S. Articles by Labbé-Jullié, C. Search for Related Content PubMed PubMed Citation Articles by Barroso, S. Articles by Labbé-Jullié, C. Social Bookmarking                      What's this?

J Biol Chem, Vol. 275, Issue 1, 328-336, January 7, 2000

Identification of Residues Involved in Neurotensin Binding and Modeling of the Agonist Binding Site in Neurotensin Receptor 1^*

Séverine Barroso, Françoise Richard, Delphine Nicolas-Ethève, Jean-Louis Reversat, Jean-Marie Bernassau, Patrick Kitabgi, and Catherine Labbé-Jullié^§

From the Institut de Pharmacologie Moléculaire et Cellulaire du CNRS, Université de Nice-Sophia Antipolis, Sophia Antipolis, 660 route des Lucioles, 06560 Valbonne and  Sanofi Recherche, Centre de Montpellier, 371 Rue du Professeur Blayac, 3418 Montpellier Cedex 04, France

The neurotensin receptor 1 (NTR1) subtype belongs to the family of G protein-coupled receptors and mediates most of the known effects of the neuropeptide including modulation of central dopaminergic transmission. This suggested that nonpeptide agonist mimetics acting at the NTR1 might be helpful in the treatment of Parkinson's disease and schizophrenia. Here, we attempted to define the molecular interactions between neurotensin-(8-13), the pharmacophore of neurotensin, and the rat NTR1. Mutagenesis of the NTR1 identified residues that interact with neurotensin. Structure-activity studies with neurotensin-(8-13) analogs identified the peptide residues that interact with the mutated amino acids in the receptor. By taking these data into account, computer-assisted modeling techniques were used to build a tridimensional model of the neurotensin-(8-13)-binding site in which the N-terminal tetrapeptide of neurotensin-(8-13) fits in the third extracellular loop and the C-terminal dipeptide binds to residues at the junction between the extracellular and transmembrane domains of the receptor. Interestingly, the agonist binding site lies on top of the previously described NTR1-binding site for the nonpeptide neurotensin antagonist SR 48692. Our data provide a basis for understanding at the molecular level the agonist and antagonist binding modes and may help design nonpeptide agonist mimetics of the NTR1.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				A. Perron, P. Sarret, L. Gendron, T. Stroh, and A. Beaudet Identification and Functional Characterization of a 5-Transmembrane Domain Variant Isoform of the NTS2 Neurotensin Receptor in Rat Central Nervous System J. Biol. Chem., March 18, 2005; 280(11): 10219 - 10227. [Abstract] [Full Text] [PDF]

				L. Gendron, A. Perron, M. D. Payet, N. Gallo-Payet, P. Sarret, and A. Beaudet Low-Affinity Neurotensin Receptor (NTS2) Signaling: Internalization-Dependent Activation of Extracellular Signal-Regulated Kinases 1/2 Mol. Pharmacol., December 1, 2004; 66(6): 1421 - 1430. [Abstract] [Full Text] [PDF]

				S. Luca, J. F. White, A. K. Sohal, D. V. Filippov, J. H. van Boom, R. Grisshammer, and M. Baldus The conformation of neurotensin bound to its G protein-coupled receptor PNAS, September 16, 2003; 100(19): 10706 - 10711. [Abstract] [Full Text] [PDF]

				D. Skrzydelski, A.-M. Lhiaubet, A. Lebeau, P. Forgez, M. Yamada, E. Hermans, W. Rostene, and D. Pelaprat Differential Involvement of Intracellular Domains of the Rat NTS1 Neurotensin Receptor in Coupling to G Proteins: A Molecular Basis for Agonist-Directed Trafficking of Receptor Stimulus Mol. Pharmacol., August 1, 2003; 64(2): 421 - 429. [Abstract] [Full Text] [PDF]

				F. Richard, S. Barroso, J. Martinez, C. Labbe-Jullie, and P. Kitabgi Agonism, Inverse Agonism, and Neutral Antagonism at the Constitutively Active Human Neurotensin Receptor 2 Mol. Pharmacol., December 1, 2001; 60(6): 1392 - 1398. [Abstract] [Full Text] [PDF]

				M. C. Gershengorn and R. Osman Minireview: Insights into G Protein-Coupled Receptor Function Using Molecular Models Endocrinology, January 1, 2001; 142(1): 2 - 10. [Abstract] [Full Text] [PDF]